<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_BIT_Basic_Part skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:BIT/Basic Part</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P>&lt;!DOCTYPE html&gt;<TITLE>Biology</TITLE></P><DIV class="navmenu navmenu-default navmenu-fixed-left offcanvas"><UL class="nav navmenu-nav"><LI><A href="https://2016.igem.org/Team:BIT">Home</A></LI><LI><A href="https://2016.igem.org/Team:BIT/Biology">Project</A></LI><LI><A href="https://2016.igem.org/Team:BIT/Human_Practices">Practice</A></LI><LI><A href="https://2016.igem.org/Team:BIT/Judging_Form">Judging</A></LI><LI><A href="https://2016.igem.org/Team:BIT/Parts_Submission"><SPAN class="style1">Parts</SPAN></A></LI><LI><A href="https://2016.igem.org/Team:BIT/HP/Silver">Achievement</A></LI><LI><A href="https://2016.igem.org/Team:BIT/Introduction">Team</A></LI></UL></DIV><DIV id="home"><DIV class="container text-center"><DIV class="content"><H4>PARTS</H4><DIV class="header-text btn"><H1><FONT color="#c91f77">B</FONT>asic <FONT color="#c91f77">P</FONT>art</H1></DIV></DIV></DIV></DIV><DIV id="subNav"><UL><LI><A href="https://2016.igem.org/Team:BIT/Parts_Submission"><H2>Parts Submission</H2></A></LI><LI class="color1"><A href="https://2016.igem.org/Team:BIT/Basic_Part"><H2>Basic Part</H2></A></LI><LI><A href="https://2016.igem.org/Team:BIT/Composite_Part"><H2>Composite Part</H2></A></LI></UL></DIV><DIV id="contain"><DIV class="container"><DIV id="words" style="float:right;width:70%"><DIV class="row text-center"><H2>Basic Part</H2></DIV><DIV class="indent"><DIV style="text-indent: 0em;"><CENTER><FONT size="1px">miRNA-155 binding site</FONT></CENTER></DIV><P>MiRNAs are widely recognized as biomarkers of many diseases. Many studies have shown that, miRNA-155 in patients with breast cancer in the body was significantly higher than normal people. After a thorough literature review , we know the recognition site of miRNA-155, of which  the transcription product, mRNA and miRNA-155 base-specific complementary matching, in order to increase its binding specificity with miRNA-155, we design four binding sites for this part,  so that when the miRNA-155 presence, it can be quickly identified by this fragment and combine to form double-stranded mRNA complex, blocking the binding of ribosomes, which will inhibit the downstream gene expression, which is called RNA-based gene silencing expression. This can serve as a switch to regulate the expression of downstream genes.
				</P></DIV></DIV></DIV></DIV></DIV></DIV><DIV id="contact"><DIV class="container"><DIV class="section-title text-center"><H2>Contact Us</H2></DIV><DIV class="row"><DIV class="col-md-3"><ADDRESS><STRONG>Address</STRONG>
					 Beijing Institute of Technology,
					No. 5 South Zhong Guan Cun Street,
					Haidian Beijing 100081, P. R. China
					Twitter : @igem_BIT

Sina Weibo : @igem_BIT

Website : http://www.bit.edu.cn
					</ADDRESS></DIV><DIV class="col-md-9"><FORM autocomplete="off"><DIV class="text-right"><A href="#" class="btn send-btn">Send</A></DIV></FORM></DIV></DIV></DIV></DIV><NAV id="footer"><DIV class="container"><DIV class="pull-right"><A href="#home" class="page-scroll">Back to Top </A></DIV></DIV></NAV></DIV></DIV></DIV></BODY></HTML>